Antipsychotic reduction and/or cessation and antipsychotics as specific treatments for tardive dyskinesia

Author:

Bergman Hanna1,Rathbone John2,Agarwal Vivek3,Soares-Weiser Karla4

Affiliation:

1. Cochrane; Cochrane Response; St Albans House 57-59 Haymarket London UK SW1Y 4QX

2. Bond University; Faculty of Health Sciences and Medicine; Robina Gold Coast Queensland Australia 4229

3. North Essex Partnership University NHS Foundation Trust; General Adult Psychiatry; The Lakes Mental Health Unit Turner Road Colchester Essex UK CO4 5JL

4. Cochrane; Cochrane Editorial Unit; St Albans House, 57 - 59 Haymarket London UK SW1Y 4QX

Publisher

Wiley

Subject

Pharmacology (medical)

Reference288 articles.

1. Risperidone for severe tardive dyskinesia: one year follow up study;Bai;International Journal of Neuropsychopharmacology,2002

2. Risperidone for pre-existing severe tardive dyskinesia: a 48-week prospective follow-up study;Bai;International Clinical Psychopharmacology,2005

3. Risperidone for severe tardive dyskinesia: a 12-week randomized, double-blind, placebo-controlled study;Bai;Journal of Clinical Psychiatry,2003

4. Pai YM Yu SC Lin CC Risperidone in reducing tardive dyskinesia: a double-blind, placebo-controlled study 155th Annual Meeting of the American Psychiatric Association; 2002 May 18-23; Philadelphia, Pennsylvania, USA 2002

5. Pai YM Yu SC Lin CC Risperidone in reducing tardive dyskinesia: a double-blind, placebo-controlled study Proceedings of the 154th Annual Meeting of the American Psychiatric Association; 2001 May 5-10; New Orleans, Louisiana, USA 2001

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号  京ICP备18003416号-3